Skip to main content
. 2019 May 3;8:e18. doi: 10.1017/jns.2019.14

Table 3.

Secondary changes to bowel movement frequency

(Mean values and standard deviations)

Lead-in period Zespri® SunGold kiwifruit Metamucil®
Parameter Mean sd Mean sd Mean sd P
No. of bowel movements/week 7·2 3·5 9·1* 4·9 8·1 3·8 0·02
No. of CBM/week 4·2 3·1 6·9* 4·3 5·5 4·2 0·002
No. of SBM/week 6·7 3·6 8·6 5·0 7·2 4·5 0·226
Number of strained bowel movements/week 3·7 2·6 1·7* 2·4 2·5* 3·4 <0·001
Average Bristol Stool Scale score 3·24 1·13 4·15* 1·26 3·52 1·27 <0·001
Proportion of bowel movements using laxatives (%) 2·8 10·9 5·2 20·9 3·4 17·7

CBM, complete bowel movements; SBM, spontaneous bowel movements.

*

Mean value was significantly different from that for the lead-in period, based on least significant difference.

Mean value was significantly different from that for Metamucil®, based on least significant difference (P = 0·025).

Not analysed. Of the participants, 92 % did not use.